Ireland's Economy Faces Slowdown Amid Rising Global Risks and U.S. Policy Uncertainty

Ireland’s economic growth is expected to slow in 2024 as global risks mount, posing a significant challenge to its multinational-driven economy, the country's central bank warned. The bank revised its forecast for modified domestic demand (MDD) to 2.7% from 3.1%, citing uncertainty affecting consumption, exports, and investment.

A key concern is Ireland’s heavy reliance on U.S. multinational corporations, which contribute significantly to employment, tax revenue, and exports. U.S. President Donald Trump’s recent criticism of Ireland’s trade surplus and low corporate tax rate has intensified fears of economic disruption. His proposed 25% tariff on pharmaceutical imports and potential tax policy shifts could heavily impact Ireland’s economy, especially if companies are incentivized to relocate production and profits back to the U.S.

The foreign multinational sector, predominantly U.S.-owned, employs 11% of Ireland’s workforce and accounts for a major share of corporate tax revenue, which makes up 26% of total tax collected. The central bank warned that policy changes in Washington could cause a fiscal shock by significantly reducing corporate tax inflows.

Despite the risks, Ireland’s pharmaceutical exports to the U.S. have surged, growing by 68% year-on-year in January, driven partly by increased demand for weight-loss drugs. While some of this may be linked to stockpiling ahead of potential tariffs, absent any trade barriers, it could provide an unexpected boost to exports.

The central bank emphasized Ireland’s vulnerability to decisions made by a few multinational firms but noted possible upsides if export trends continue. As uncertainty looms, policymakers must navigate these risks to safeguard economic stability.